Friday was a doozy for many biotech and pharmaceutical companies after news broke late Thursday that President-elect Donald Trump would nominate vaccine-skeptic Robert F. Kennedy Jr. to the nation's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback